The sensitivity around the HPV vaccine comes from the fact that HPV is sexually transmitted.
GlaxoSmithkline ( GSK - news - people ) is developing its own HPV vaccine.
This discovery kick-started HPV vaccine programs at drug giants such as Merck and small biotechs like Gaithersburg, Md.
At Merck, Kathrin Jansen started the HPV vaccine program and has shepherded it through eight years of development.
As of 2010, about one-third of girls had an HPV vaccine, although this was up from 16 percent in 2008.
FORBES: Merck & Its HPV Vaccine: Sales & Skepticism Are Both Up
Merck ( MRK - news - people )'s HPV vaccine, Gardasil, now heavily promoted for cervical cancer.
One preventative solution: Merck (nyse: MRK - news - people ) has developed a phenomenal HPV vaccine.
The HPV vaccine will protect against types 16 and 18 which are the two most common types causing cervical cancer.
His latest anti-vax screed is an attack on Gardasil, the HPV vaccine.
Girls are offered the HPV vaccine at secondary school when aged 12-13.
This discovery inspired HPV vaccine programs at such drug giants as Merck and small biotechs as MedImmune in Gaithersburg, Maryland, which supplies the GlaxoSmithKline vaccine.
At Merck, where Jansen runs the program to create an HPV vaccine, scientists are expected to begin final-phase human trials of one promising candidate.
So the HPV vaccine, that is often recommended for girls, should extend to boys as well, say researchers from Innsbruck Medical University in Austria.
McKinney says she had heard about the HPV vaccine, but she had never heard about the test for the virus until a nurse handed her an informational brochure.
One preventative solution: Merck has developed a phenomenal HPV vaccine.
Merck revealed during a conference call that it would pay royalties totaling about 25% to other companies, including GlaxoSmithKline and CSL Limited of Australia, on sales of the HPV vaccine.
The advisory committee also voted that Cervarix, a new HPV vaccine made by GlaxoSmithKline, appeared to be safe and effective for girls and young women 10 to 25 years of age.
And maintaining high HPV vaccine coverage is extremely important because figures show cervical screening coverage is declining among 25-29-year-olds with some evidence of increasing cancer incidence at younger ages, they pointed out.
We now can also protect women against cervical cancer through the relatively new HPV vaccine, which is one of the largest cancer killers of women in the developing world with more than 275, 000 deaths each year.
FORBES: GAVI Alliance CEO: Leadership Is About Vision and Responsibility, Not Power
So while the HPV vaccine by itself is probably far too expensive to justify, if it's coupled with a larger agenda, laying the groundwork for decreasing maternal mortality and improving child health by reaching these girls before they become mothers, then perhaps we have a real breakthrough.
In October 2009, one HPV (human papillomavirus) vaccine, Gardasil, was approved by the Food and Drug Administration for use in males in addition to females from 9 to 26 years of age.
Some experts are also concerned about how to get the expensive vaccine to the developing world, where HPV is an even greater scourge.
During that time, Clark may only get to launch one drug with really big potential: Gardasil, a vaccine for the human papilloma virus, or HPV, which causes cervical cancer.
However, that was also the first full year after the FDA approved the vaccine for preventing warts caused by certain strains of the HPV in boys and men.
FORBES: Merck & Its HPV Vaccine: Sales & Skepticism Are Both Up
Researchers have also argued that it might make sense to vaccinate boys as well, because the vaccine also prevents genital warts, and because men pass the HPV virus to women.
The vaccine works by preventing a sexually transmitted disease--the human papillomavirus, or HPV--that infects some 20 million Americans and is the main cause of cervical cancer.
应用推荐